Rahul Dhanda is the Senior Vice President of Corporate Development since February 2016. He joined T2 Biosystems in January 2008 and has held several leadership roles including Vice President of Marketing since 2010. Prior to joining T2 Biosystems, Rahul worked in marketing at Boston Scientific’s Urology division, where he led the team responsible for the Access, Visualization and Laser Lithotripsy franchises, representing roughly $100 million in annual revenue. Prior to Boston Scientific, Rahul worked in business development at Interleukin Genetics, where he helped negotiate the firm’s acquisition by Alticor, Inc. as well as multiple other deals. Rahul earned his M.B.A. from MIT’s Sloan School of Management and his B.A. from Wesleyan University. He is a former committee member of the AAAS Committee on Scientific Freedom and Responsibility. Rahul is the author of several publications, an inventor on numerous patents and applications, and has authored the first book to address the crossroads between industry and bioethics/public policy, entitled Guiding Icarus: Merging Bioethics with Corporate Interests.